EUVIMEDEUVIMED entdecken
Systematische ÜbersichtFallberichtOpen Access · CC BY-NC-ND 4.0

Atrial Arrhythmias in Cardiac Sarcoidosis—Case Presentation and Systematic Review

Emily C Hodkinson iD, Luis Quininir, Edward Hsiao, Rajesh Puranik, Raymond W Sy

Pacing and Clinical Electrophysiology · 2025-12 · 48 (12) · 1384-1395

DOI: 10.1111/pace.70062 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Pacing and Clinical Electrophysiology, online erschienen am 26.09.2025. Verfasst von Emily C Hodkinson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia. Hauptthemen laut MEDLINE: Sarcoidosis, Cardiomyopathies, Atrial Fibrillation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcoidosis is a rare idiopathic, multiorgan disease with clinical cardiac involvement in approximately 5% of cases. Diagnosis and management of cardiac sarcoidosis (CS) have mainly focused on impaired LV function, ventricular arrhythmias, and atrio‐ventricular conduction disease. Atrial arrhythmias (AA) may be an under‐recognized manifestation of sarcoidosis, and the purpose of the study was to perform a systematic review of the current literature, with an emphasis on the prevalence and management of AA in CS. AA occur as a result of direct infiltration of granulomatous disease in the atria or secondary to atrial myopathic changes from pulmonary or ventricular disease. Positron emission tomography (PET) is the modality of choice for surveillance of disease activity in the atria. AA occur frequently, in up to 40% in patients with CS, and may be associated with frequent hospitalization and reduction in quality of life. Moreover, AA may be the predominant cardiac manifestation, and there should be some consideration to include AA as part of future iterations of the diagnostic criteria for CS. Contemporary treatment involves a combination of immunosuppression, anti‐arrhythmic therapy, and catheter ablation, but recurrence occurs more frequently than in patients with non‐CS AA. Further systematic studies, likely in the form of multi‐center observational cohort studies, are required to inform guidelines on the specific management of AA in CS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcoidosisCardiomyopathiesAtrial FibrillationHumansMale

Stichwörter der Autor:innen

EP studyPETatrial fibrillationatrial fluttercardiac sarcoidosisimmunosuppression

Autor:innen und Institutionen

  • Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Facultad De Medicina, Universidad De La Frontera, Temuco, Chile.
  • Mater Imaging, Sydney, Australia.
  • Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

ORCID-Profile: Emily C Hodkinson

Zitieren

APA

Hodkinson, E. C., Quininir, L., Hsiao, E., Puranik, R., & Sy, R. W. (2025). Atrial Arrhythmias in Cardiac Sarcoidosis—Case Presentation and Systematic Review. Pacing and Clinical Electrophysiology, 48(12), 1384-1395. https://doi.org/10.1111/pace.70062

Vancouver

Hodkinson EC, Quininir L, Hsiao E, Puranik R, Sy RW. Atrial Arrhythmias in Cardiac Sarcoidosis—Case Presentation and Systematic Review. Pacing and Clinical Electrophysiology. 2025;48(12):1384-1395. doi:10.1111/pace.70062

BibTeX
@article{Hodkinson2025,
  author = {Hodkinson, Emily C and Quininir, Luis and Hsiao, Edward and Puranik, Rajesh and Sy, Raymond W},
  title = {Atrial Arrhythmias in Cardiac Sarcoidosis—Case Presentation and Systematic Review},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2025},
  volume = {48},
  number = {12},
  pages = {1384--1395},
  doi = {10.1111/pace.70062}
}
Kostenlos starten →